Apellis Pharmaceuticals (APLS) Stock Chart & Stock Price History $27.97 +0.35 (+1.27%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$27.92 -0.04 (-0.16%) As of 08/22/2025 06:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Apellis Pharmaceuticals Stock Price Performance The Apellis Pharmaceuticals (APLS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 30.27%, with a year-to-date return of -12.35%. In the past month, the stock has increased 39.22%, reflecting recent market activity. As of the latest close, Apellis Pharmaceuticals traded at $27.97 with a market cap of $3.53 billion and volume of 1.82 million shares. Five years ago, the stock traded at $28.19, representing a 0.78% decrease over that period. At the time, it had a market cap of $2.29 billion and a volume of 705,027 shares. Receive APLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Apellis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.84%1 Month Performance+39.22%3 Month Performance+60.38%Year-To-Date Performance-12.35%1 Year Performance-30.27%5 Year Performance-0.78% APLS Stock Chart for Sunday, August, 24, 2025 APLS Chart by TradingView Apellis Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$27.62$27.97+1.27%$28.26$27.431.82 million shs$3.53 billion08/21/2025$26.58$27.62+3.91%$27.67$26.232.00 million shs$3.49 billion08/20/2025$26.68$26.58-0.37%$27.11$26.361.74 million shs$3.36 billion08/19/2025$27.35$26.68-2.45%$27.35$26.582.85 million shs$3.37 billion08/18/2025$27.75$27.35-1.44%$28.12$27.331.95 million shs$3.45 billion08/15/2025$27.62$27.75+0.47%$28.87$27.633.88 million shs$3.50 billion08/14/2025$26.58$27.62+3.91%$27.85$26.063.64 million shs$3.49 billion08/13/2025$23.90$26.58+11.21%$26.68$24.004.70 million shs$3.36 billion08/12/2025$23.85$23.90+0.21%$24.45$23.751.54 million shs$3.02 billion08/11/2025$24.37$23.85-2.13%$24.48$23.811.23 million shs$3.01 billion Get the Latest News and Ratings for APLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Apellis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$24.33$24.37+0.16%$24.63$23.881.34 million shs$3.08 billion08/07/2025$23.73$24.33+2.53%$24.42$23.232.60 million shs$3.07 billion08/06/2025$24.20$23.73-1.94%$24.01$23.422.09 million shs$3.00 billion08/05/2025$24.26$24.20-0.25%$24.64$23.803.91 million shs$3.06 billion08/04/2025$22.95$24.26+5.71%$24.32$22.893.40 million shs$3.05 billion08/01/2025$22.34$22.95+2.73%$23.57$22.044.08 million shs$2.88 billion07/31/2025$19.00$22.34+17.58%$23.56$20.457.00 million shs$2.39 billion07/30/2025$18.95$19.00+0.26%$20.17$18.883.85 million shs$2.39 billion07/29/2025$18.75$18.95+1.07%$19.45$18.485.51 million shs$2.38 billion07/28/2025$19.59$18.75-4.29%$20.01$18.722.66 million shs$2.36 billion07/25/2025$20.09$19.59-2.49%$20.30$19.332.93 million shs$2.46 billion07/24/2025$19.90$20.09+0.95%$20.32$19.164.64 million shs$2.52 billion07/23/2025$19.89$19.90+0.05%$20.40$19.752.44 million shs$2.50 billion Related Companies VTRS Stock Price Chart ASND Stock Price Chart RDY Stock Price Chart QGEN Stock Price Chart MRNA Stock Price Chart BBIO Stock Price Chart VRNA Stock Price Chart ELAN Stock Price Chart BPMC Stock Price Chart ROIV Stock Price Chart Receive APLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Apellis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:APLS) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apellis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apellis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access